In this week's Homerun Slides, incretins, an explanation of the glucose-stimulated secretion of insulin and the effect of exenatide versus glargine insulin on insulin secretion in type 2 diabetes...
Read More »Play It Safe With at Least TWO Pharmacies
With the prevalence of mail-order pharmacies, I’ve always recommended that my patients use their local pharmacy for at least one prescription. Why? If an emergency arises, and they need a medication or supplies right away, they can get great service locally because they have established a relationship
Read More »Imperium: World’s First Instant Insulin Patch
Unilife Corporation has launched the world’s first instant insulin patch, Imperium. Imperium is a prefilled, preassembled, multi-day wearable insulin pump for continuous subcutaneous insulin infusion and on-demand bolus delivery through the push of a button. It is equipped with Bluetooth connectivity to wirelessly connect with smartphone apps for patient reminders …
Read More »Modifications of Preprandial or ISA Regimens to Accommodate Gastroparesis – Part 10
Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 10 Chapter 22 Gastroparesis Modifications of Preprandial or ISA Regimens to Accommodate Gastroparesis It takes a while for your physician to select and fine-tune a program to improve stomach-emptying. In the meantime, it’s possible to reduce the frequency and severity …
Read More »The Present and Future of Insulin Therapy Part 6
In this week's Homerun Slides, we see how sulfonylureas, metformin and TZDs work in the treatment type 2 diabetes...
Read More »Difference in Treatment Satisfaction Between Long- versus Intermediate-Acting Basal Insulin in Combination with Oral Antidiabetic Agents
New research has suggested medication combination can optimize patients’ quality of life… Neural protamine Hagedorn (NPH) is an intermediate insulin that reduces blood glucose levels. Its peak in activity is at 4-6 hours after administration and duration of action is between 12-16 hours. Glargine duration of action is prolonged to …
Read More »Insulin Initiation in Children and Adolescents with T1D
Proper diabetes education at a young age can reduce amount of common errors… The primary clinical objective to be achieved with insulin therapy initiation is the elimination of ketosis and hyperglycemic events with prevention of chronic problems. Insulin therapy is the primary management of type 1 diabetes, which should be …
Read More »Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Many people are unaware about the health outcome associated with switching from glargine to detemir… Type 2 diabetes is often managed by antidiabetic oral agents. As the disease progresses, it creates a need for insulin therapy. Insulin has significant impact on patients’ quality of life as well as financial circumstance. …
Read More »The Present and Future of Insulin Therapy Part 5
In this week’s Homerun Slides, we take a look at the prevention of beta cell failure in type 2 diabetes…
Read More »The Present and Future of Insulin Therapy Part 4
In this week’s Homerun Slides, we take a look at the beta cell mass and pathogenesis of type 2 diabetes… To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 4 …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.